Orkla India IPO Allotment Status: Check Your Shares
Exciting news for IPO investors! Orkla India's share allotment is now finalized. Discover how to check your status, current GMP trends, and what's next for this FMCG giant's market debut.
Exciting news for IPO investors! Orkla India's share allotment is now finalized. Discover how to check your status, current GMP trends, and what's next for this FMCG giant's market debut.
Jayesh Logistics makes disappointing market debut with shares opening below issue price. Expert analysis on what went wrong and future outlook for the logistics stock.
Lenskart, India's leading eyewear retailer, is generating massive investor interest with its upcoming IPO. Get the latest on GMP, expected dates, price band, and expert review of this highly anticipated public offering.
Orkla India's highly anticipated IPO allotment is likely to be finalized today. Discover the latest grey market premium and learn how to check your share allocation status online through BSE and registrar portals.
Digital payments leader Pine Labs announces IPO price band of ₹210-221 per share. Discover key dates, issue size, and what makes this fintech giant's public offering a market game-changer.
As the Studds Accessories IPO enters its final day, discover why investors are rushing to subscribe. Get expert analysis on GMP trends, subscription status, and whether this two-wheeler gear specialist is worth your investment.
Comprehensive analysis of Indian stock market trends featuring Nifty 50 technical setup, Lenskart IPO updates, US-China trade talks impact, and 8 high-potential stock recommendations for savvy investors.
SpaceX's Starlink ramps up India operations with new job openings while navigating regulatory challenges. Plus: Cognizant's IPO plans, Skyroot's rocket launch, and key business developments shaping India's tech landscape.
Shadowfax Technologies files for IPO with impressive growth but faces significant concentration risk as top 10 clients contribute 60% of revenue. Discover the challenges and opportunities for this logistics unicorn.
Get ready for a blockbuster week in Indian markets! Groww IPO, Pine Labs IPO, and multiple other public issues set to open. Complete breakdown of dates, price bands, and investment opportunities.
November 2025 is set to witness a blockbuster IPO season with five major companies including Groww, boAt, and PhysicsWallah going public. Get complete details on issue sizes, dates, and investment potential.
As Lenskart and Studds Accessories prepare for their IPOs, grey market premiums reveal exciting listing gain potential. Discover which eyewear giant and helmet manufacturer might deliver better returns.
Lenskart's upcoming IPO could value the eyewear giant at Rs 70,000 crore with a staggering 260x PE ratio. Discover the growth potential, risks, and expert analysis behind this much-anticipated public offering.
Shreeji Global FMCG Limited announces its ₹22.50 crore IPO opening on November 4, 2025, with price band of ₹90-95 per share. Learn about company prospects and investment opportunities.
Indian markets closed the week on a high note with Nifty hitting 19,047 and Sensex gaining 1%. Discover the top gainers, mutual fund launches, and global market trends that shaped this bullish week.
India's leading CA coaching institute, Swapnil Patni's Classes, secures strategic investment from Sunil Singhania's family office ahead of potential IPO, marking significant growth phase for the education sector.
Orkla India's highly anticipated IPO allotment is nearing completion. Discover the latest grey market premium, learn how to check your share status online, and get expert insights on what to expect next.
India's IPO market is witnessing unprecedented demand with oversubscriptions reaching ₹200 crore per hour. Discover why this boom is different from previous market frenzies and what it means for investors.
In a major market development, SEBI Chairman Madhabi Puri Buch announces all regulatory obstacles for NSE's long-awaited IPO have been resolved. Discover what this means for investors and Indian capital markets.
Exclusive insights from Groww CFO Ishan Bansal on how the fintech giant plans to deploy IPO proceeds across technology enhancement, brand amplification, and NBFC business expansion in competitive Indian market.
The Orkla India IPO has taken the market by storm, getting oversubscribed nearly 49 times by day three. Discover the latest GMP and what's driving this massive investor frenzy.
Lenskart's IPO witnesses overwhelming response on Day 1 with full subscription. Discover investor sentiment, valuation details, and what this means for India's eyewear market leader.
Lenskart's massive ₹7,278 crore IPO witnesses overwhelming response with full subscription on opening day. Strong QIB and retail participation indicate massive investor confidence in the eyewear giant's market potential.
Indian investment platform Groww announces ₹95-100 per share price band for its highly anticipated November 4 IPO, marking a significant milestone in the fintech sector.
Texfab Renaissance's SME IPO allotment is likely finalized today. Discover the latest grey market premium and a simple guide to check your share allocation status online. Don't miss out!
Prince's Group sets sights on massive $1.56 billion valuation through London IPO, potentially marking the beginning of UK market's recovery with strong investor interest.
Orkla India's IPO concludes today with strong institutional interest. Discover the latest GMP, subscription figures, and expert analysis on whether you should invest in this FMCG ingredients manufacturer.
Orkla India's highly anticipated IPO shows promising grey market premium signals. Get complete details on subscription status, price band, and expert review before investing.
Lenskart's highly anticipated IPO gains momentum with premium GMP signals. Discover the eyewear unicorn's valuation, price band details, and market debut timeline in our exclusive analysis.
Lenskart's much-anticipated IPO preparations accelerate with grey market premium hitting ₹150. Discover key details about valuation, subscription dates, and whether you should apply for this eyewear disruptor's public offering.